CENTER OVERVIEW
Wetlin Research Associates, Inc. is a California-based corporation founded by Bernard Michlin, MD, in 1998 with the sole purpose of providing quality research to the pharmaceutical industry as well as allowing patients to benefit from the no-cost cutting-edge advances in pharmacological therapies. We provide outpatient and clinical trials. We focus primarily on Phase II, III, and IV studies.
Our most important goal has always been to improve the quality of research performance and data collection while also bringing numerous investigators together under one roof to provide a diversity of research potential and increase potential subjects for any given protocol.
We pride ourselves in our ability to provide a 24-hour turnaround time on regulatory documents and our ability to perform a given protocol within 2 days after being contacted by a pharmaceutical company.
Our patient database allows us to perform a criteria-specific search and provide an honest answer as to whether we feel we can meet the enrollment objectives of a study efficiently.
To help meet our patients’ needs, we begin seeing patients at 7:00 A.M. and frequently hold office visits on Saturdays.
FACILITY DESCRIPTION
Our facility is located within a multi-specialty private practice with its own dedicated research department. This area provides locked storage for each individual study.
We have a dedicated refrigerator 2–8 degrees centigrade, a -20 degree centigrade freezer, a laboratory processing area with centrifuge and other lab equipment, pulmonary function testing, pulse-oximetry, cardiac stress testing, Holter monitoring, stationary ECG, and DEXA bone densitometry.
Our patients within our practice are in an electronic database, which allows us to feed any parameters into the database and extract the exact number of subjects we have available for any given protocol parameters.
We are located within the Alvarado Hospital Medical Center complex, which houses over 200 physicians and is within 2 blocks of Alvarado Hospital, which has a 24-hour Emergency Department.
PRIMARY INVESTIGATOR
Bernard A. Michlin, M.D.
Internal Medicine, Board Certified
SUB-INVESTIGATOR
Laurie Reeves, PA-C, MMS
STUDY COORDINATORS
Shira Michlin, RN
Liliana Sanchez
OUR SPONSORS/CROS
Amgen, Smithkline Beecham
Knoll Pharmaceutical Company
Bio-Technology General Corp.
Shire Laboratories Inc.
Novo Nordisk Pharmaceuticals Inc.
Bristol-Myers Squibb
Pfizer
Novartis
PPD
MTRA
Quintiles
ICON
Premier Research Worldwide and Ingenix
Sanofi-Aventis
Takeda
Johnson & Johnson
Covance
Pharmanet
AstraZeneca